Estrogen, cognition, and a woman's risk of Alzheimer's disease

American Journal of Medicine

Volumn 103, Issue 3 A, 1997, Pages 11S-18S

  Henderson, Victor W ^a  

^a Depts Neurol (Div Cogn N   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030818060     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00261-1     Document Type: Conference Paper

References (100)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 76:1987;465-479.
2. Mölsä PK, Marttila RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand. 65:1982;541-552.
3. Rorsman B, Hagnell O, Lanke J. Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology. 15:1986;122-129.
4. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol. 25:1989;317-324.
5. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology. 43:1993;515-519.
6. Jarvik LF. Human intelligence: sex differences. Acta Genet Med Gemellol. 24:1975;189-211.
7. Halpern DF. Sex Differences in Cognitive Abilities. 1992;Lawrence Erlbaum, Hillsdale, NJ.
8. McGlone J. Sex differences in human brain asymmetry: a critical survey. Behav Brain Sci. 3:1980;215-263.
9. Shaywitz BA, Shaywitz SE, Pugh KR, et al. Sex differences in the functional organization of the brain for language. Nature. 373:1995;607-609.
10. Henderson VW, Buckwalter JG. Cognitive deficits of men and women with Alzheimer's disease. Neurology. 44:1994;90-96.
11. Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol. 50:1993;757-760.
12. Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology. 45:1995;299-302.
13. Cohen D, Wilkie F. Sex-related differences in cognition among the elderly. Wittig MA, Petersen AC. Sex-Related Differences in Cognitive Functioning. 1979;145-157 Academic Press, New York.
14. Ganguli M, Ratcliff G, Huff FJ, et al. Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology. 10:1991;42-52.
15. Jaffe RB. The menopause and perimenopausal period. Yen SSC, Jaffe RB. Reproductive Endocrinology. 3rd ed. 1991;389-408 WB Saunders, Philadelphia.
16. Kawata M. Roles of steroid hormones and their receptors in structural organization in the nervous system. Neurosci Res. 24:1995;1-46.
17. Matsumoto A. Synaptogenic action of sex steroids in developing and adult neuroendocrine brain. Psychoneuroendocrinology. 16:1991;25-40.
18. Bachevalier J, Hagger C. Sex differences in the development of learning abilities in primates. Psychoneuroendocrinology. 16:1991;177-188.
19. Williams CL, Meck WH. The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology. 16:1991;155-176.
20. Chung SK, Pfaff DW, Cohen RS. Estrogen-induced alterations in synaptic morphology in the midbrain central gray. Exp Brain Res. 69:1988;522-530.
21. Toran-Allerand CD. Organotypic culture of the developing cerebral cortex and hypothalamus: relevance to sexual differentiation. Psychoneuroendocrinology. 16:1991;7-24.
22. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 336:1993;293-306.
23. Lustig RH. Sex hormone modulation of neural development in vitro. Hormon Behav. 28:1994;383-395.
24. Miranda RC, Sohrabji F, Toran-Allerand CD. Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: a basis for potential developmental interactions of estrogen with neurotrophins. Mol Cell Neurosci. 4:1993;510-525.
25. Sohrabji F, Miranda RC, Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci. 14:1994;459-471.
26. Shughrue PJ, Dorsa DM. Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology. 57:1993;439-447.
27. 3H-oestradiol. Nature. 289:1981;500-502.
28. Loy R, Gerlach JL, McEwen BS. Autoradiographic localization of estradiol-binding neurons in the rat hippocampal formation and entorhinal cortex. Dev Brain Res. 39:1988;245-251.
29. Toran-Allerand CD, Miranda RC, Bentham WDL, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA. 89:1992;4668-4672.
30. Weiland NG. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinol. 131:1992;662-668.
31. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 14:1994;7680-7687.
32. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
33. Desjardins GC, Beaudet A, Meaney MJ, Brawer JR. Estrogen-induced hypothalamic beta-endorphin neuron loss: a possible model of hypothalamic aging. Exp Gerontol. 30:1995;253-267.
34. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem. 269:1994;13065-13068.
35. Applebaum-Bowden D, McLean P, Steinmetz A, et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res. 30:1989;1895-1906.
36. Kushwaha RS, Foster DM, Barrett PHR, Carey KD, Bernard MG. Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp). Metabolism. 40:1991;93-100.
37. Muesing RA, Miller VT, LaRosa JC, Stoy DB, Phillips EA. Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution. J Clin Endocrinol Metab. 75:1992;1250-1254.
38. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 90:1993;1977-1981.
39. Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6-mediated "acute phase response" in the brain? Immunol Today. 12:1991;217-219.
40. Bauer J, Ganter U, Strauss S, et al. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol. 143:1992;650-657.
41. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 41:1993;176-181.
42. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol. 172:1995;1273-1278.
43. Ohkura T, Teshima Y, Isse K, et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause. 2:1995;13-18.
44. Bishop J, Simpkins JW. Role of estrogens in peripheral and cerebral glucose utilization. Rev Neurosci. 3:1992;121-137.
45. Niki E, Nakano M. Estrogens as antioxidants. Method Enzymol. 186:1990;330-333.
46. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 45:1993;509-511.
47. Sagara Y, Dargusch R, Klier FG, Schubert D, Behl C. Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J Neurosci. 16:1996;497-505.
48. Lindheim SR, Legro RS, Bernstein L, et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol. 167:1992;1831-1836.
49. Davis KL, Davis BM, Greenwald BS, et al. Cortisol and Alzheimer's disease. Am J Psychiatry. 143:1986;442-446.
50. Heuser IJ, Litvan I, Juncos JL, et al. Cortisol baseline secretion and memory performance in patients with dementia of the Alzheimer type. Agnoli A, Cahn J, Lassen N, Mayeux R. Senile Dementias: II International Symposium. 1988;351-353 John Libbey Eurotext, Paris.
51. De Leon MJ, McRae T, Iasi JR, et al. Abnormal hypercortisolemic response in Alzheimer's disease linked to hippocampal atrophy. Lancet. ii:1988;391-392.
52. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci. 14:1994;2893-2903.
53. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol. 5:1995;205-216.
54. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
55. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Garcon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA. 271:1994;985-991.
56. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
57. Kimura D, Hampson E. Cognitive pattern in men and women is influenced by fluctuations in sex hormones. Curr Dir Psychol Sci. 3:1994;57-61.
58. Van Goozen SHM, Cohen-Kettenis PT, Gooren LJG, Frijda NH, Van de Poll NE. Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology. 20:1995;343-363.
59. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 13:1988;345-357.
60. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
61. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol. 83:1994;979-983.
62. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc. 42:1994;919-922.
63. Henderson VW, Watt L, Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 21:1996;421-430.
64. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA. 269:1993;2637-2641.
65. Doody RS, Young R, Lynn P, Cooke N, Rosenfeld JE. Estrogen and psychomotor performance. (Abstr.). J Neuropsych Clin Neurosci. 7:1995;410.
66. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Austral. 2:1977;162-163.
67. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord. 14:1988;177-187.
68. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;991-995.
69. Best NR, Rees MP, Barlow DH, Cowen PJ. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology. 17:1992;87-93.
70. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol. 80:1992;30-36.
71. Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women: relation to obesity, fat mass, age and years post-menopause. Clin Endocrinol. 9:1978;59-66.
72. Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol. 57:1981;624-628.
73. Berlinger WG, Potter JF. Low body mass index in demented outpatients. J Am Geriatr Soc. 1991:1991;973-978.
74. Wolf-Klein GP, Silverstone FA, Levy AP. Nutritional patterns and weight change in Alzheimer patients. Intern Psychogeriatr. 4:1992;103-118.
75. Buckwalter JG, Schneider LS, Wilshire TW, Dunn ME, Henderson VW. Body weight, estrogen and cognitive functioning in Alzheimer's disease: an analysis of the tacrine study group. Arch Gerontol Geriatr. 24:1997;261-267.
76. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
77. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system - senile dementia (Alzheimer's type). J Steroid Biochem. 34:1989;521-525.
78. Honjo H, Ogino Y, Tanaka K, et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia - Alzheimer's type: a placebo-controlled double blind study. J Japan Menopause Soc. 1:1993;167-171.
79. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine J. 41:1994;361-371.
80. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1:1994;125-130.
81. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 51:1994;896-900.
82. Birge SJ. The role of estrogen deficiency in the aging central nervous system. Lobo RA. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. 1994;153-157 Raven Press, New York.
83. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatr Clin Neurosci. 7:1995;334-337.
84. Lerner A, Cole R, Debanne S, et al. Immunological and endocrine conditions in an Alzheimer's disease case-control study. (Abstr.). Neuroepidemiology. 14:1995;307.
85. Heyman A, Wilkinson WE, Stafford JA, Helms JJ, Sigmon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol. 15:1984;335-341.
86. Amaducci LA, Fratiglioni L, Rocca WA, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology. 36:1986;922-931.
87. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology. 40:1990;1698-1707.
88. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol. 28:1990;766-774.
89. Paganini-Hill A, Henderson V. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 140:1994;256-261.
90. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 140:1994;262-267.
91. Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
92. Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med. 98:(suppl 1A):1995;76S-79S.
93. Vermeulen A. Androgens in the aging male. J Clin Endocrinol Metab. 73:1991;221-224.
94. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci. 108:1994;325-332.
95. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol. 46:1993;211-219.
96. Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN. Evidence of a healthy estrogen user survivor effect. Epidemiology. 6:1995;227-231.
97. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol. 85:1995;6-10.
98. Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med. 20:1991;47-63.
99. Folsom AR, Mink PJ, Sellers TA, Hong C-P, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 85:1995;1128-1132.
100. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 87:1996;6-12.